However, ASK1 inhibition with selonsertib significantly reduces liver fibrosis in Nlrp3 KI mice (as demonstrated by a 33.5% reduction in hydroxyproline levels when compared to untreated Nlrp3 KI controls). This evidence concerns the gene NLRP3 and Hepatic fibrosis.